{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T04:29:07Z","timestamp":1786681747087,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangdong Provincial Natural Science Foundation General Program","award":["2022A1515010392"],"award-info":[{"award-number":["2022A1515010392"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-026-02154-5","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T18:36:16Z","timestamp":1779388576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Methylation-based biomarkers from thin-prep cytology test samples for early detection of cervical cancer: application and clinical potential"],"prefix":"10.1186","volume":"18","author":[{"given":"Zhihan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guorong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunshi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baochen","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabo","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoliang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"issue":"2","key":"2154_CR1","first-page":"229","volume":"112","author":"A Buskwofie","year":"2020","unstructured":"Buskwofie A, David-West G, Clare CA. A review of cervical cancer: incidence and disparities. J Natl Med Assoc. 2020;112(2):229\u201332.","journal-title":"J Natl Med Assoc"},{"issue":"3","key":"2154_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"2154_CR3","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.6004\/jnccn.2023.0062","volume":"21","author":"NR Abu-Rustum","year":"2023","unstructured":"Abu-Rustum NR, Yashar CM, Arend R, Barber E, Bradley K, Brooks R, et al. NCCN Guidelines(R) insights: cervical cancer, Version 1.2024. J Natl Compr Canc Netw. 2023;21(12):1224\u201333.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"2154_CR4","doi-asserted-by":"publisher","first-page":"96 e91","DOI":"10.1016\/j.ajog.2019.12.017","volume":"223","author":"LA Wise","year":"2020","unstructured":"Wise LA, Willis SK, Perkins RB, Wesselink AK, Klann A, Crowe HM, et al. A prospective study of treatments for cervical intraepithelial neoplasia and fecundability. Am J Obstet Gynecol. 2020;223(1):96 e91-96 e15.","journal-title":"Am J Obstet Gynecol"},{"key":"2154_CR5","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.2147\/CMAR.S203059","volume":"11","author":"DD Yan","year":"2019","unstructured":"Yan DD, Tang Q, Chen JH, Tu YQ, Lv XJ. Prognostic value of the 2018 FIGO staging system for cervical cancer patients with surgical risk factors. Cancer Manag Res. 2019;11:5473\u201380.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"2154_CR6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41598-019-57202-3","volume":"10","author":"X Liu","year":"2020","unstructured":"Liu X, Wang W, Hu K, Zhang F, Hou X, Yan J, et al. A risk stratification for patients with cervical cancer in stage IIIC1 of the 2018 FIGO staging system. Sci Rep. 2020;10(1):362.","journal-title":"Sci Rep"},{"issue":"49","key":"2154_CR7","doi-asserted-by":"publisher","first-page":"80735","DOI":"10.18632\/oncotarget.12598","volume":"7","author":"R Wang","year":"2016","unstructured":"Wang R, van Leeuwen RW, Boers A, Klip HG, de Meyer T, Steenbergen RD, et al. Genome-wide methylome analysis using MethylCap-seq uncovers 4 hypermethylated markers with high sensitivity for both adeno- and squamous-cell cervical carcinoma. Oncotarget. 2016;7(49):80735\u201350.","journal-title":"Oncotarget"},{"issue":"6","key":"2154_CR8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1159\/000450595","volume":"60","author":"AT Lorincz","year":"2016","unstructured":"Lorincz AT. Virtues and weaknesses of DNA methylation as a test for cervical cancer prevention. Acta Cytol. 2016;60(6):501\u201312.","journal-title":"Acta Cytol"},{"issue":"1","key":"2154_CR9","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1186\/s12885-018-5125-8","volume":"18","author":"M Schmitz","year":"2018","unstructured":"Schmitz M, Eichelkraut K, Schmidt D, Zeiser I, Hilal Z, Tettenborn Z, et al. Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages. BMC Cancer. 2018;18(1):1197.","journal-title":"BMC Cancer"},{"issue":"1","key":"2154_CR10","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1186\/s12885-024-13082-z","volume":"24","author":"X Chen","year":"2024","unstructured":"Chen X, Jiang H, Xu H, Wang L, Liu P, Ma D, et al. Cervical cancer screening: efficacy of PAX1 and JAM3 methylation assay in the triage of atypical squamous cell of undetermined significance (ASC-US). BMC Cancer. 2024;24(1):1385.","journal-title":"BMC Cancer"},{"key":"2154_CR11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2147\/CMAR.S417877","volume":"15","author":"C Fan","year":"2023","unstructured":"Fan C, Ma Q, Wu X, Dai X, Peng Q, Cai H. Detection of DNA methylation in gene loci ASTN1, DLX1, ITGA4, RXFP3, SOX17, and ZNF671 for diagnosis of cervical cancer. Cancer Manag Res. 2023;15:635\u201344.","journal-title":"Cancer Manag Res"},{"key":"2154_CR12","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2147\/OTT.S277445","volume":"14","author":"C Zhang","year":"2021","unstructured":"Zhang C, Fu S, Wang L, Wang F, Wu D, Zhe X, et al. The value and clinical significance of ZNF582 gene methylation in the diagnosis of cervical cancer. Onco Targets Ther. 2021;14:403\u201311.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"2154_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1083\/jcb.142.1.117","volume":"142","author":"I Mart\u00ecn-Padura","year":"1998","unstructured":"Mart\u00ecn-Padura I, Lostaglio S, Schneemann M, Williams L, Romano M, Fruscella P, et al. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol. 1998;142(1):117\u201327.","journal-title":"J Cell Biol"},{"issue":"Pt 19","key":"2154_CR14","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1242\/jcs.00704","volume":"116","author":"K Ebnet","year":"2003","unstructured":"Ebnet K, Aurrand-Lions M, Kuhn A, Kiefer F, Butz S, Zander K, et al. The junctional adhesion molecule (JAM) family members JAM-2 and JAM-3 associate with the cell polarity protein PAR-3: a possible role for JAMs in endothelial cell polarity. J Cell Sci. 2003;116(Pt 19):3879\u201391.","journal-title":"J Cell Sci"},{"issue":"1","key":"2154_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13148-022-01388-3","volume":"14","author":"W Yang","year":"2022","unstructured":"Yang W, Guo C, Herman JG, Zhu C, Lv H, Su X, et al. Epigenetic silencing of JAM3 promotes esophageal cancer development by activating Wnt signaling. Clin Epigenetics. 2022;14(1):164.","journal-title":"Clin Epigenetics"},{"key":"2154_CR16","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.2147\/CMAR.S189937","volume":"11","author":"D Zhou","year":"2019","unstructured":"Zhou D, Tang W, Zhang Y, An HX. JAM3 functions as a novel tumor suppressor and is inactivated by DNA methylation in colorectal cancer. Cancer Manag Res. 2019;11:2457\u201370.","journal-title":"Cancer Manag Res"},{"issue":"12","key":"2154_CR17","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1080\/17501911.2025.2535942","volume":"17","author":"H Wang","year":"2025","unstructured":"Wang H, Wen C, Xie J, Wang J, Yang W. Epigenetic silencing of JAM3 promoted progression in serous ovarian carcinoma through PI3K\/AKT pathway. Epigenomics. 2025;17(12):803\u201315.","journal-title":"Epigenomics"},{"issue":"7","key":"2154_CR18","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1097\/IGC.0000000000001011","volume":"27","author":"T Luan","year":"2017","unstructured":"Luan T, Hua Q, Liu X, Xu P, Gu Y, Qian H, et al. PAX1 methylation as a potential biomarker to predict the progression of cervical intraepithelial neoplasia: a meta-analysis of related studies. Int J Gynecol Cancer. 2017;27(7):1480\u20138.","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"2154_CR19","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1002\/ijc.26326","volume":"130","author":"JJ Eijsink","year":"2012","unstructured":"Eijsink JJ, Lendvai \u00c1, Deregowski V, Klip HG, Verpooten G, Dehaspe L, et al. A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients. Int J Cancer. 2012;130(8):1861\u20139.","journal-title":"Int J Cancer"},{"issue":"1","key":"2154_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s12905-024-03127-7","volume":"24","author":"J Peng","year":"2024","unstructured":"Peng J, Chen Y, Yin A. JAM3 promotes cervical cancer metastasis by activating the HIF-1\u03b1\/VEGFA pathway. BMC Womens Health. 2024;24(1):293.","journal-title":"BMC Womens Health"},{"key":"2154_CR21","doi-asserted-by":"publisher","first-page":"1181982","DOI":"10.3389\/fonc.2023.1181982","volume":"13","author":"L Kong","year":"2023","unstructured":"Kong L, Wang L, Wang Z, Xiao X, You Y, Wu H, et al. Cytological DNA methylation for cervical cancer screening: a validation set. Front Oncol. 2023;13:1181982.","journal-title":"Front Oncol"},{"issue":"7","key":"2154_CR22","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1007\/s12094-022-02783-1","volume":"24","author":"X Chen","year":"2022","unstructured":"Chen X, Yu D, Zhou H, Zhang X, Hu Y, Zhang R, et al. The role of EphA7 in different tumors. Clin Transl Oncol. 2022;24(7):1274\u201389.","journal-title":"Clin Transl Oncol"},{"key":"2154_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17101493","author":"M Liu","year":"2016","unstructured":"Liu M, Zhou K, Cao Y. MicroRNA-944 affects cell growth by targeting EPHA7 in non-small cell lung cancer. Int J Mol Sci. 2016. https:\/\/doi.org\/10.3390\/ijms17101493.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2154_CR24","first-page":"6139","volume":"24","author":"HY Liu","year":"2020","unstructured":"Liu HY, Chang J, Li GD, Zhang ZH, Tian J, Mu YS. MicroRNA-448\/EPHA7 axis regulates cell proliferation, invasion and migration via regulation of PI3K\/AKT signaling pathway and epithelial-to-mesenchymal transition in non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 2020;24(11):6139\u201349.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"2154_CR25","first-page":"575","volume":"23","author":"D Li","year":"2014","unstructured":"Li D, Xiang B, Ying XX, Ying XX, Dong H. Correlation analysis of EphA7 expression with clinico-pathological parameters and prognosis in tongue squamous cell carcinoma. Shanghai Kou Qiang Yi Xue. 2014;23(5):575\u20139.","journal-title":"Shanghai Kou Qiang Yi Xue"},{"issue":"1","key":"2154_CR26","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1186\/s12885-022-09653-7","volume":"22","author":"W Zhang","year":"2022","unstructured":"Zhang W, Cao H, Yang J, Zhao J, Liang Z, Kang X, et al. The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer. BMC Cancer. 2022;22(1):636.","journal-title":"BMC Cancer"},{"issue":"10","key":"2154_CR27","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1002\/ijc.31778","volume":"143","author":"S Ren","year":"2018","unstructured":"Ren S, Gaykalova D, Wang J, Guo T, Danilova L, Favorov A, et al. Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma. Int J Cancer. 2018;143(10):2425\u201336.","journal-title":"Int J Cancer"},{"key":"2154_CR28","first-page":"1184","volume":"103","author":"Branch of Cancer P","year":"2023","unstructured":"Branch of Cancer P, Control CPMA, Chinese O, Gynecology Association C, Cervical Neoplasia C, Chinese Society of C, et al. [Chinese expert consensus on the use of human papillomavirus nucleic acid testing for cervical cancer screening (2022)]. Zhonghua Yi Xue Za Zhi. 2023;103:1184\u201395.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"1","key":"2154_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/LGT.0000000000000710","volume":"27","author":"LS Massad","year":"2023","unstructured":"Massad LS, Perkins RB, Naresh A, Nelson EL, Spiryda L, Gecsi KS, et al. Colposcopy standards: guidelines for endocervical curettage at colposcopy. J Low Genit Tract Dis. 2023;27(1):97\u2013101.","journal-title":"J Low Genit Tract Dis"},{"issue":"8","key":"2154_CR30","doi-asserted-by":"publisher","first-page":"100528","DOI":"10.1016\/j.modpat.2024.100528","volume":"37","author":"J de Waard","year":"2024","unstructured":"de Waard J, Bhattacharya A, de Boer MT, van Hemel BM, Esajas MD, Vermeulen KM, et al. Methylation analysis to detect CIN3+ in high-risk human papillomavirus-positive self-samples from the population-based cervical cancer screening program. Mod Pathol. 2024;37(8):100528.","journal-title":"Mod Pathol"},{"issue":"1","key":"2154_CR31","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1186\/s12879-021-06355-6","volume":"21","author":"Y Huang","year":"2021","unstructured":"Huang Y, Pan H, Xu X, Lv P, Wang X, Zhao Z. Droplet digital PCR (ddPCR) for the detection and quantification of Ureaplasma spp. BMC Infect Dis. 2021;21(1):804.","journal-title":"BMC Infect Dis"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-026-02154-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02154-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02154-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T04:05:22Z","timestamp":1786680322000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13148-026-02154-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2154"],"URL":"https:\/\/doi.org\/10.1186\/s13148-026-02154-5","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This investigation was conducted in strict compliance with the Declaration of Helsinki and received ethical approval from the Institutional Review Board of Guangzhou First People\u2019s Hospital (Approval No.: K-2021-109-05).","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have reviewed and approved the manuscript and consent to its publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"156"}}